ABCB5 and colorectal cancer: Overexpression of miR-522 in HT29/DOX cells brought about decreased levels of ABCB5 protein levels, suggesting that miR-522 mimics could be a promising treatment approach for overcoming chemoresistance in colorectal cancer (Yang et al., 2015).